In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes.

Chagla, Zain

Chagla, Zain.

Affiliation

Chagla Z; St. Joseph's Healthcare, Hamilton, Ontario, Canada (Z.C.).

Ann Intern Med ; 177(1): JC7, 2024 01.

Article in En | MEDLINE | ID: mdl-38163374

ABSTRACT

ABSTRACT

SOURCE CITATION Sommer I, Ledinger D, Thaler K, et al. Outpatient treatment of confirmed COVID-19 a living, rapid evidence review for the American College of Physicians (version 2). Ann Intern Med. 2023;1761377-1385. 37722115.

Subject(s)

COVID-19; Cytidine; Hydroxylamines; Lactams; Leucine; Nitriles; Outpatients; Proline; Humans; Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Cytidine/analogs & derivatives; Ritonavir/therapeutic use; SARS-CoV-2

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Outpatients / Proline / Cytidine / COVID-19 / Hydroxylamines / Lactams / Leucine / Nitriles Limits: Humans Language: En Journal: Ann Intern Med Year: 2024 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google